Surya Roshni Ltd Share Price – NSE  / BSE

Capital Goods-Non Electrical Equipment, Small Cap

As per the company?s exchange filing, the order is slated for delivery by 31 March 2026. The firm also clarified that neither its promoters nor members of the promoter group have any interest in the awarding authority, confirming that the transaction does not qualify as a related-party deal under regulatory norms.

Surya Roshni is the largest exporter of ERW Pipes, largest producer of ERW GI pipes and one of the largest lighting companies in India.

The company's consolidated net profit surged 117.2% to Rs 74.19 crore, while net sales rise 20.7% to Rs 1,845.16 crore in Q2 FY26 over Q2 FY25.

Powered by Capital Market - Live News

Securities in F&O Ban:

SAIL & Sammaan Capital shares are banned from F&O on 25 November 2025.

Stocks to Watch:

Surya Roshini has received the order for the supply of spiral pipes with external 3 LPE coating, valued at Rs 105.18 crore, to be executed by 31 March 2026.

Eris Lifesciencesl board approved acquiring remaining 30% stake in Swiss Parenterals (Swiss) for Rs 423.3 crore via share-swap. The deal makes Swiss a 100% subsidiary

Paras Defence and Space Technologies has signed a memorandum of association (MoU) with Inter-University Accelerator Centre (IUAC), New Delhi to develop commercial- grade MRI magnet system for indigenous manufacturing in the country to make India a Self-Reliant in superconducting MRI Magnet technology.

Housing & Urban Development Corporation (Hudco) has signed memorandum of understanding (MoU) with Naional Institute of Urban Affairs (NIUA) to explore collaborations with multi-lateral funding agencies and other suitable financing opportunities.

Ceigall India has received a letter of intent (LoI) from REC Power Development Consultancy (PDCL) to establish Velgaon Substation. The consideration of said order is Rs 58.5 crore annually for 35 years.

Dr Reddy?s Laboratories announced that the European Commission (EC) has granted marketing authorization for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab).

Powered by Capital Market - Live News

Surya Roshni has received an order of Rs 105.18 crore from an engineering and infrastructure company for supply of spiral pipes with external 3 LPE coating.

Powered by Capital Market - Live News

Surya Roshni announced that the Board of Directors of the Company at its meeting held on 11 November 2025, inter alia, have recommended the interim dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News